Your support is critical to ensuring that the voices of Canadians living with Parkinson's are heard through all levels of government.
Walk with us. We are here for you.
Register for SuperWalk today
Your Support Makes Our Voices Heard
Parkinson Canada SuperWalk is YOUR opportunity to change the course of Parkinson’s in Canada. Through SuperWalk, you directly support a better life today for Canadians living with Parkinson’s; a world without Parkinson’s tomorrow.
Supporting Advocacy plays a major role in a "better life today".
We are the national authority speaking on issues that impact the Parkinson community. There are over 150 Parkinson’s Ambassadors in communities across Canada making our voice heard on important issues every day. With a federal election looming in 2019, we are working hard to make sure that Parkinson's is at the forefront. Our goal is to have representation in every one of the 338 Federal Electoral Districts.
With the support of our ambassador network, our Public Affairs team leads advocacy initiatives including reduced wait times, access to medications and much more on a provincial, federal and local basis. This includes working directly with provincial, federal and local government to share concerns felt in communities across the country around access to trained Parkinson specialists and to help set the healthcare policy across the country. These efforts take time, but are targeted at making sure people in across the country have access to medications, trained clinicians and other essential services and supports for managing Parkinson’s.
Some of the most important recent government initiatives resulting from our advocacy work include:
- In 2017 Apomorphine (MOVAPO) received a positive recommendation by the Canadian Agency for Drugs and Technologies in Health. Parkinson Canada filed a patient evidence submission for the review process that was informed by a survey from nearly 900 people with Parkinson’s and caregivers
- As a result of strong social action the Public Health Agency Surveillence System added Parkinson’s disease to the Canadian Chronic Disease Surveillance System. This means the incidence of the disease will be tracked year over year which is critical information to gather in order to ensure government investments keep pace with the growing needs of Parkinson’s patients